The effect of CYP2C9 gene polymorphisms on blood pressure lowering response to losartan in patients with essential hypertension

Creative Commons License

Tanrikulu F. P., BABAOĞLU M. Ö., ÇAKIR B., BOZKURT A., Guven G. S.

CUKUROVA MEDICAL JOURNAL, vol.47, no.3, pp.1015-1023, 2022 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 47 Issue: 3
  • Publication Date: 2022
  • Doi Number: 10.17826/cumj.1093761
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Academic Search Premier, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.1015-1023
  • Keywords: Hypertension, losartan, CYP2C9, genetic polymorphism, pharmacogenetics, CLINICAL-RELEVANCE, VARIANTS, GENOTYPE
  • Hacettepe University Affiliated: Yes


Purpose: In this study, the possible effects of CYP2C9 polymorphisms on the clinical response to losartan were investigated in a group of hypertensive patients.